Key result
Women carrying the DD or ID genotypes of the ACE I/D polymorphism had a 72% elevated risk of developing idiopathic recurrent pregnancy loss compared to those with the II genotype.
Why the study?
Does the ACE I/D polymorphism increase the risk of idiopathic recurrent pregnancy loss in women?
Case-Control (n=1,176)
No
Does the ACE I/D polymorphism increase the risk of idiopathic recurrent pregnancy loss in women?
The ACE I/D polymorphism (DD or ID genotypes) is significantly associated with an increased risk of idiopathic recurrent pregnancy loss in a Turkish population.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice; hypothesis-generating for ACE I/D in idiopathic recurrent pregnancy loss.
OBJECTIVES: Idiopathic recurrent pregnancy loss (IRPL) is one of the most troublesome complications of pregnancy. Several researches were also conducted to search the possible association with ACE I/D polymorphism and IRPL. In the light of these reports, this case-control study was investigated to genotypes and alleles of ACE I/D polymorphism in IRPL group and control group. MATERIAL AND METHODS: Overall, 1176 subjects (1007 cases, 169 controls) were investigated. Allele genotype distributions were determined by PCR method in both groups. Differences in genotype and allele frequencies between groups were investigated by Pearson chi-square tests. The odds ratio (OR) and 95% confidence intervals (95% CI) were also determined. RESULTS: For the ACE I/D polymorphism I and D allele frequencies were in the control and case groups respectively; 49.4 and 41.6%, 50.6 and 58.4%. The genotypes of ACE for I/D observed in control and case group respectively were as follows; II (27.2 and 17.9), ID (44.4 and 47.4) and DD (28.4 and 34.7). Regarding the distribution of D allele and genotypes containing D allele, we observed significant statistical differences between case and control groups. CONCLUSIONS: Our results showed that the ACE I/D polymorphism was associated with IRPL, and that women that carried DD or ID genotypes had a 72% elevated risk of developing IRPL than women with the II genotype (OR (95% CI): 1.72 (1.181-2.5)). This odds ratio was found to be 1.61 in a case-control study and 1.28 in a meta-analysis study compiling 11 separate studies, which is consistent with our study data.
No takes yet. Share an insight, caveat, or question.
Evren Gümüş (2018) conducted a case-control in Idiopathic recurrent pregnancy loss (n=1,176). ACE I/D polymorphism (DD or ID genotypes) vs. ACE II genotype was evaluated on Idiopathic recurrent pregnancy loss (OR 1.72, 95% CI 1.181-2.500, p=0.00433). Women carrying the DD or ID genotypes of the ACE I/D polymorphism had a 72% elevated risk of developing idiopathic recurrent pregnancy loss compared to those with the II genotype.
Synapse has enriched 10 related papers. Consider them for comparative context: